RAPT Therapeutics (RAPT) Shares Outstanding (Weighted Average): 2018-2024
Historic Shares Outstanding (Weighted Average) for Therapeutics (RAPT) over the last 7 years, with Dec 2024 value amounting to $4.4 million.
- Therapeutics' Shares Outstanding (Weighted Average) rose 1.63% to $4.4 million in Q4 2024 from the same period last year, while for Sep 2024 it was $4.4 million, marking a year-over-year increase of 1.59%. This contributed to the annual value of $4.4 million for FY2024, which is 1.63% up from last year.
- Latest data reveals that Therapeutics reported Shares Outstanding (Weighted Average) of $4.4 million as of FY2024, which was up 1.63% from $4.3 million recorded in FY2023.
- Therapeutics' 5-year Shares Outstanding (Weighted Average) high stood at $4.4 million for FY2024, and its period low was $3.1 million during FY2020.
- Over the past 3 years, Therapeutics' median Shares Outstanding (Weighted Average) value was $4.3 million (recorded in 2023), while the average stood at $4.1 million.
- Data for Therapeutics' Shares Outstanding (Weighted Average) shows a peak YoY increased of 20.32% (in 2021) over the last 5 years.
- Therapeutics' Shares Outstanding (Weighted Average) (Yearly) stood at $3.1 million in 2020, then increased by 20.32% to $3.7 million in 2021, then increased by 1.23% to $3.7 million in 2022, then increased by 15.00% to $4.3 million in 2023, then rose by 1.63% to $4.4 million in 2024.